Takara Bio Overview

  • Founded
  • 2002
Founded
  • Status
  • Public
  • Employees
  • 1,539
Employees
  • Stock Symbol
  • 4974
Stock Symbol
  • Investments
  • 5
  • Share Price
  • $29.77
  • (As of Friday Closing)

Takara Bio General Information

Description

Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.

Contact Information

Website
www.takara-bio.co.jp
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Food Products
Other Industries
Drug Discovery
Biotechnology
Stock Exchange
TKS
Primary Office
  • Nojihigashi 7-4-38
  • Kusatsu, Shiga 525-0058
  • Japan
+81 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Takara Bio Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$29.77 $29.41 $24.76 - $31.79 $3.59B 120M 257K $1.18

Takara Bio Financials Summary

In Thousands,
USD 		TTM 30-Jun-2021 FY 2021 31-Mar-2021 FY 2020 31-Mar-2020 FY 2019 31-Mar-2019
EV 3,005,524 3,028,890 2,309,552 2,611,088
Revenue 510,932 434,612 317,890 323,261
EBITDA 235,365 162,666 81,199 73,138
Net Income 142,407 90,032 35,123 32,984
Total Assets 901,507 813,575 694,058 640,696
Total Debt 0 10,343 10,363 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Takara Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business s
Food Products
Kusatsu, Japan
1,539 As of 2021

00000000

ehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cu
0000000000000
San Diego, CA
000 As of 0000
0.000 0000-00-00
000000&0

00000000

nderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupid
0000000000000
Germantown, MD
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Takara Bio Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioLegend Corporate Backed or Acquired San Diego, CA 000 000000&0
00000000 Formerly VC-backed Germantown, MD 000 00000 000000000 00000
00000000 Formerly VC-backed San Diego, CA 0000 00000 000000&0
000000 00000000000 Corporation Plymouth Meeting, PA 000 000.00 00000000 000.00
000000 000000000 Formerly PE-Backed Codolet, France 000 000000&0
You’re viewing 5 of 11 competitors. Get the full list »

Takara Bio Executive Team (1)

Name Title Board Seat Contact Info
Koichi Nakao President, Chief Executive Officer & Board Member
To view Takara Bio’s complete executive team members history, request access »

Takara Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Takara Bio Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 26-Apr-2006 00000 00000 00 0000 Decision/Risk Analysis
000000 000 000 01-Aug-2005 000000000000000000 0000 Discovery Tools (Healthcare)
000000000 23-Feb-2005 00000 00000 00 00.00 Biotechnology
0000000000 26-Nov-2002 00000 00000 00 0000 Decision/Risk Analysis
Helixmith 01-Mar-2000 Corporate 000 Biotechnology
To view Takara Bio’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

Takara Bio Exits (4)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000000 26-Apr-2006 00000 00000 00 0000 Completed
  • 4 buyers
000000000 23-Feb-2005 00000 00000 00 00.00 Completed
  • 9 buyers
0000000000 26-Nov-2002 00000 00000 00 0000 Completed
  • 3 buyers
Helixmith 01-Mar-2000 Corporate 000 Completed
To view Takara Bio’s complete exits history, request access »